Waukegan, IL, United States of America

Udara Anulal Premachandra Ilandari Dewage

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Udara Anulal Premachandra Ilandari Dewage

Introduction

Udara Anulal Premachandra Ilandari Dewage, an inventive mind based in Waukegan, IL, has made significant strides in the field of pharmaceuticals. His innovative work primarily focuses on the development of macrolide compounds aimed at combating infectious diseases.

Latest Patents

Udara holds one patent titled "Macrolides with modified desosamine sugars and uses thereof." This patent details novel macrolide compounds specifically designed for the treatment of infectious diseases. The compounds include 14-membered ketolides and 14-15-membered azaketolides, which may incorporate modified sugars that are desosamine analogues. An intriguing feature of these macrolides is their potential bicyclic structure. Additionally, the patent discusses pharmaceutical compositions and methods for treating infections caused by Gram-negative bacteria, showcasing the practical implications of his research.

Career Highlights

Throughout his career, Udara has demonstrated a commitment to innovation in health sciences. His work on macrolides represents a significant advancement in pharmaceutical research, particularly in developing effective treatments for challenging bacterial infections. The detailed methods provided for the preparation of these macrolides also highlight his technical expertise.

Collaborations

Udara collaborates with notable colleagues including Andrew G Myers and Ziyang Zhang. These collaborations play a crucial role in augmenting research efforts and enhancing the impact of their collective work in the field.

Conclusion

Udara Anulal Premachandra Ilandari Dewage continues to push the boundaries of innovation in pharmaceutical science. His patent on macrolides signifies a pivotal development in treating infectious diseases, reflecting his dedication to improving public health through scientific advancements. With ongoing collaborations and a robust research background, his contributions are likely to influence the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…